Dokter CT scan seluruh tubuh terbaik di luar negeri — Halaman 3

Assoc. Prof. Priv.-Doz. Dr. Alexander W. Hauswirth is a specialist in internal medicine and haemato‑oncology at JUVENIS. Since 2010, he has served as the lead senior physician for Haematology/Haemostaseology and Oncology at the Clinic for Internal Medicine I, Medical University of Vienna/AKH Vienna, Austria’s largest hospital.

He earned his medical degree from the University of Vienna in 1999. He received the venia docendi in 2010 and was appointed Associate Professor in 2012. He completed an additional haemato‑oncology qualification in 2014. As a Schrödinger Fellow in Salamanca in 2009–2010, he researched CLL stem and precursor cells. He has published regularly since 2000.

Accreditations include Austrian Medical Chamber diplomas in emergency medicine (since 2009) and sports medicine (2018). Awards include the Schrödinger Fellowship (2009), the ÖGHO award (2009), and the European Society of Chemotherapy poster award (2003). Clinical focus: anaemias, leukaemias, lymph node disorders, clotting and anticoagulation, and pre‑operative clearance. Languages: German and English.

Dr. Shady Mohammed El-sebai adalah Kepala Radiologi Intervensional di National Cancer Institute, Universitas Kairo. Beliau berspesialisasi dalam pencitraan onkologi dan prosedur invasif minimal. Dr. El-sebai menangani tumor hati, ginjal, dan jaringan lunak menggunakan teknik kemoembolisasi dan ablasi. Beliau bekerja di Rumah Sakit Onkologi Shef Al Orman, sebuah pusat yang terakreditasi ESMO.

• Melakukan ablasi gelombang mikro dan frekuensi radio untuk lesi tulang, paru-paru, dan tiroid.
• Pakar dalam biopsi yang dipandu USG dan CT, termasuk eksisi lesi payudara dengan Mammotome.
• Berspesialisasi dalam embolisasi arteri rahim untuk fibroid dan ablasi varises.
• Menangani kasus bilier dan ginjal yang kompleks dengan pemasangan stent perkutan dan drainase.

Prof. Beni Boursi adalah spesialis bersertifikat ganda dalam onkologi dan penyakit dalam di Sheba Medical Center. Beliau menggunakan CT scan seluruh tubuh untuk mengidentifikasi kanker sejak dini.

• Menyelesaikan pelatihan subspesialisasi lanjutan dalam epidemiologi kanker di University of Pennsylvania
• Pernah menjabat sebagai clinical fellow di MD Anderson Cancer Center dan Mayo Clinic
• Mengembangkan model prediktif untuk diagnosis dini kanker kolorektal dan pankreas
• Mempublikasikan penelitian di jurnal ilmiah utama termasuk Science dan platform pendidikan ASCO
• Anggota Asosiasi Onkologi Klinis dan Radioterapi Israel

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Dr. Yaacov Lawrence adalah Kepala Onkologi Radiasi di Sheba Medical Center. Beliau memiliki spesialisasi dalam terapi radiasi presisi dan neuro-onkologi. Dr. Lawrence adalah pelopor bedah radio pleksus celiac untuk manajemen nyeri kanker pankreas. Beliau memegang gelar FASTRO, salah satu penghargaan tertinggi di bidang spesialisasi beliau.

• Memimpin Program Kanker Gastrointestinal di Sheba Medical Center.
• Melakukan bedah radio stereotaktik untuk tumor otak dan kanker sistem saraf.
• Penulis lebih dari 280 publikasi ilmiah tentang protokol radiasi yang dipersonalisasi.
• Menyelesaikan pelatihan fellowship onkologi radiasi di Thomas Jefferson University.

Dr. Shute Ailia DAE is a medical oncologist at Optimed International Çorlu Hospital. Dr. Ailia graduated from Dokuz Eylül University Faculty of Medicine in 2013 and completed an internal medicine residency at Bezmialem Vakıf University Hospital in 2018. A hematology–oncology fellowship at Başkent University Hospital followed in 2023.

From 2018 to 2020, Dr. Ailia served as an internal medicine specialist at Bezmialem Vakıf University Hospital. From 2023 to 2024, Dr. Ailia was an instructor in medical oncology at Başkent University Adana Dr. Turgut Noyan Practice and Research Center.

Clinical focus includes breast, lung, and prostate cancers. It also covers gastrointestinal cancers (colon, stomach, esophagus, pancreas, liver), lymphomas, melanoma, and gynecologic and genitourinary cancers. Languages: English, Turkish, Swahili.

Dokter ini adalah seorang ahli radiologi berpengalaman dengan latar belakang klinis yang luas di berbagai institusi medis. Masa kerja profesionalnya mencakup posisi di klinik radiologi Universitas Erciyes Kayseri dan Rumah Sakit Negara Kayseri, serta peran di berbagai pusat medis swasta, termasuk Academy Medical Center, Anaclinic Medical Center, dan klinik radiologi Rumah Sakit Liman.

Dengan karier yang berfokus pada pencitraan diagnostik, dokter ini telah memberikan layanan radiologi di pusat medis swasta Samsun Private Midiliv dan yang terbaru di Rumah Sakit Samsun Büyük Anadolu. Dokter ini memiliki keahlian komprehensif dalam radiologi klinis, yang berkontribusi pada akurasi diagnostik dan perawatan pasien di berbagai lingkungan layanan kesehatan.

Dokter ini adalah ahli radiologi yang sangat serbaguna dengan keahlian luas di berbagai modalitas pencitraan diagnostik dan intervensi. Kemahiran klinis mencakup radiologi abdomen, Doppler, obstetri, payudara, muskuloskeletal, pediatrik, dan neuroradiologi, memastikan dukungan diagnostik yang komprehensif bagi beragam populasi pasien.

Selain pencitraan diagnostik, dokter ini terampil dalam melakukan prosedur intervensi non-vaskular, memberikan solusi invasif minimal untuk kondisi klinis yang kompleks. Pendekatan multidisiplin ini memungkinkan akurasi diagnostik yang tepat dan intervensi terapeutik yang efektif di berbagai spesialisasi medis.

Dokter adalah spesialis medis dengan keahlian di bidangnya. Mereka berdedikasi untuk memberikan perawatan klinis berkualitas tinggi dan menjaga standar profesional dalam praktik medis.

Dr. Erkan Karatas adalah dokter bedah THT dan maksilofasial di Rumah Sakit Universitas Atlas di Istanbul. Beliau memiliki spesialisasi dalam bedah dasar tengkorak dan pemasangan implan koklea. Dr. Karatas telah berkontribusi pada lebih dari 100 artikel medis. Beliau menyelesaikan pelatihan spesialis di pusat-pusat bergengsi di AS, Jerman, Italia, dan Swiss.

• Anggota dari 11 asosiasi profesional, termasuk American Academy of Otolaryngology.
• Pakar dalam operasi kompleks untuk kanker tiroid, lidah, dan laring.
• Melakukan prosedur khusus seperti stapedektomi, timpanoplasti, dan bedah ortognatik.
• Bekerja di rumah sakit terakreditasi AACI yang menangani 565.000 pasien setiap tahun.

Dr. Ercan Kocakoc adalah ahli radiologi pemenang penghargaan di Rumah Sakit Medical Park Bahcelievler di Istanbul. Beliau memenangkan Juara 1 pada kongres ESGAR tahun 2009 untuk kasus klinis. Dr. Kocakoc berspesialisasi dalam radiologi intervensi dan pencitraan tubuh tingkat lanjut. Beliau menyelesaikan fellowship penelitian di University Hospital of Cleveland di AS.

• Melakukan kemoembolisasi dan radioembolisasi hati untuk pasien kanker.
• Mengobati kondisi urologis melalui prosedur seperti embolisasi varikokel.
• Pernah menjabat sebagai ketua di Universitas Bezmialem Vakif dan Yeditepe.
• Anggota European Society of Gastrointestinal and Abdominal Radiology.

Dr. Karen Drumea adalah onkolog senior dan spesialis radioterapi di Rambam Medical Center. Beliau menggunakan pencitraan seperti CT scan seluruh tubuh untuk memantau pasien kanker.

• Spesialis onkologi – menangani berbagai jenis kanker dengan terapi target
• Pakar radioterapi – menggunakan radiasi untuk mengecilkan tumor dan membunuh sel kanker
• Berpraktik di Rambam Medical Center – rumah sakit dan pusat penelitian utama di Israel
• Memberikan konsultasi untuk kasus kanker kompleks yang memerlukan hasil pencitraan diagnostik terperinci

Dokter ini adalah ahli radiologi yang sangat berprestasi dengan pengalaman klinis luas selama lebih dari dua dekade. Lulusan Fakultas Kedokteran Universitas Istanbul, dokter ini telah menyelesaikan pelatihan khusus dalam radiologi dan pernah memegang posisi di berbagai pusat pencitraan dan institusi medis bergengsi, termasuk Neolife Medical Center. Keahlian klinis dokter didukung oleh latar belakang yang kuat dalam pencitraan diagnostik, dengan fokus khusus pada neuroradiologi dan aplikasi MRI tingkat lanjut.

Dokter ini adalah anggota aktif dari beberapa organisasi profesional, termasuk RSNA dan European Society of Radiology. Sepanjang kariernya yang terkemuka, dokter ini telah memberikan kontribusi signifikan terhadap literatur medis melalui berbagai publikasi yang ditinjau oleh rekan sejawat dan telah menerima berbagai penghargaan atas keunggulan dalam pencitraan diagnostik dan presentasi studi kasus.

Dr. Brenda Pastrana adalah ahli bedah onkologi di Rumah Sakit Galenia yang terakreditasi JCI di Cancún. Beliau berspesialisasi dalam kanker payudara, tiroid, dan sistem pencernaan. Dr. Pastrana memiliki sertifikasi dari CONACEM. Beliau meraih gelar kedokteran dari Universidad Autónoma de México.

• Melakukan mastektomi, reseksi hati, dan operasi kanker usus besar yang kompleks.
• Merawat pasien di fasilitas yang memegang Status Berlian dari Accreditation Canada.
• Dosen universitas di Universidad Anáhuac.
• Anggota Masyarakat Onkologi Meksiko (SMEO).

Dr. Gokhan Yilmaz adalah dokter bedah umum di Rumah Sakit Medipol University Pendik di Istanbul. Beliau memiliki spesialisasi dalam bedah kolorektal, gastrointestinal, dan bariatrik. Dr. Yilmaz sebelumnya menjabat sebagai Asisten Profesor di Universitas Medipol Istanbul. Beliau menempuh pelatihan di Rumah Sakit Pelatihan dan Penelitian Okmeydanı, sebuah institusi medis terkemuka di Turki.

• Melakukan prosedur kompleks seperti gastric sleeve, gastric bypass, dan balon lambung.
• Menangani kondisi termasuk hernia inguinalis, kista pankreas, dan penyakit fibrokistik payudara.
• Melakukan penelitian bedah dan melatih dokter bedah baru sebagai anggota fakultas universitas.
• Bekerja di fasilitas yang meraih 95,4 dari 96,4 poin untuk kualitas layanan kesehatan.

Dr. Gurkan Danisan adalah profesor madya dan ahli radiologi intervensi di Rumah Sakit Distrik Medipol Acibadem. Beliau berspesialisasi dalam intervensi neurovaskular, onkologi, dan arteri perifer. Dr. Danisan melakukan prosedur invasif minimal seperti angiografi dan biopsi terpandu untuk berbagai kondisi. Beliau bekerja di fasilitas terakreditasi JCI menggunakan teknologi robotik untuk perawatan pasien.

• Memegang keanggotaan di European Society of Neuroradiology dan ESR.
• Merupakan anggota Cardiovascular and Interventional Radiological Society of Europe.
• Pernah menjabat sebagai asisten profesor di Rumah Sakit Pelatihan dan Penelitian Universitas Sakarya.
• Menangani penyakit vaskular kompleks dan melakukan intervensi non-vaskular yang presisi.

Dr. Didem Karacetin adalah ahli onkologi radiasi di Rumah Sakit Universitas Biruni di Istanbul. Beliau menyelesaikan pelatihan klinis di Princess Margaret Hospital di Toronto. Dr. Karacetin adalah mantan Kepala Departemen Onkologi Radiasi di Universitas Ilmu Kesehatan. Beliau berspesialisasi dalam radioterapi intraoperatif untuk kanker payudara dan brakiterapi untuk tumor ginekologi.

• Memiliki gelar Master dalam Fitoterapi dari Universitas Istanbul.
• Bersertifikat dalam aplikasi hidrogel SpaceOAR untuk pengobatan kanker prostat.
• Mengobati kanker paru-paru, otak, dan gastrointestinal menggunakan radiasi terarah.
• Berpraktik di Rumah Sakit Universitas Biruni, yang memegang sertifikasi kualitas TEMOS dan ISO.

Dr. Senem Karabulut adalah ahli onkologi medis di Rumah Sakit Universitas Biruni di Istanbul. Beliau adalah seorang profesor dan memegang gelar PhD dalam onkologi molekuler. Dr. Karabulut disertifikasi oleh European Society for Medical Oncology (ESMO). Sebelumnya, beliau pernah berlatih sebagai pengamat di Rumah Sakit Universitas di New Jersey, AS.

• Mengkhususkan diri dalam imunoterapi dan perawatan terarah untuk kanker gastrointestinal dan payudara.
• Menangani tumor sistem hepatobilier, kanker paru-paru, dan keganasan genitourinari.
• Berkualifikasi melalui ujian dewan Turkish Medical Oncology Society.
• Berpraktik di Rumah Sakit Universitas Biruni, fasilitas yang terakreditasi TEMOS.

Dr. Atakan Topcu adalah onkolog medis di Rumah Sakit Medipol Acibadem District di Istanbul. Beliau berspesialisasi dalam pengobatan tumor padat termasuk kanker paru-paru, payudara, dan kolorektal. Dr. Topcu adalah Associate Professor dengan lebih dari 50 publikasi ilmiah yang ditinjau oleh rekan sejawat. Beliau duduk di Dewan Redaksi jurnal medis BMC Cancer.

• Keahlian dalam imunoterapi, terapi target, dan perawatan onkologi geriatri.
• Mengobati malnutrisi terkait kanker, kaheksia, dan sarkopenia.
• Anggota aktif European Society for Medical Oncology (ESMO).
• Bekerja di rumah sakit terakreditasi JCI yang berspesialisasi dalam perawatan onkologi tingkat lanjut.

Dr. Turkan Ozturk Topcu adalah onkolog klinis di Rumah Sakit Universitas Biruni di Istanbul. Beliau menjaga hubungan profesional dengan MD Anderson Cancer Center di AS. Beliau berspesialisasi dalam pengobatan kanker payudara, paru-paru, dan gastrointestinal. Dr. Topcu adalah anggota ESMO dan ASCO.

• Menyelesaikan fellowship di Klinik Kanker Payudara Sunnybrook Odette Cancer Center di Kanada.
• Menangani berbagai kondisi termasuk kanker hati, pankreas, dan ginekologi.
• Memegang peran klinis di institusi besar seperti Moffitt Cancer Center di AS.
• Bekerja di Rumah Sakit Universitas Biruni, fasilitas yang terakreditasi TEMOS di Turki.